The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study

Abstract

The Wellcome Trust, the Bill & Melinda Gates Foundation, the UK Medical Research Council, the European and Developing Countries Clinical Trials Partnership 2 and 3, the NIHR Oxford Biomedical Research Centre, and the Serum Institute of India, Open Philanthropy.